Expectedly, a reported 2- to 3-fold increase in insulin secretion is observed in individuals with obesity [19] and prediabetes [20–22] due to β-cell compensation, which is shown to eventually lead to β-cell damage and reduction in β-cell mass/volume. This evidence concerns the gene INS and obesity disorder.